Cannabis constituents reduce seizure behavior in chemically-induced and scn1a-mutant zebrafish.

Epilepsy Behav

Department of BioMolecular Sciences, School of Pharmacy, University of Mississippi, University, MS 38677, United States of America. Electronic address:

Published: September 2020

AI Article Synopsis

  • Current antiepileptic drugs (AEDs) are often ineffective for certain epilepsy types like Dravet syndrome, and can have severe side effects; Epidiolex, a CBD-based drug, is a recent treatment option but may cause liver toxicity.
  • A study compared the effects of various cannabis-derived compounds (CBD, THC, CBDV, CBN, LN) on seizure-like activity in zebrafish models for chemically-induced seizures and Dravet syndrome.
  • Results showed that CBD and THC effectively reduced chemically-induced seizure activity, while compounds including CBN and LN also reduced seizures in the Dravet model, indicating potential therapeutic benefits for a broader range of cannabis-derived substances.

Article Abstract

Current antiepileptic drugs (AEDs) are undesirable for many reasons including the inability to reduce seizures in certain types of epilepsy, such as Dravet syndrome (DS) where in one-third of patients does not respond to current AEDs, and severe adverse effects that are frequently experienced by patients. Epidiolex, a cannabidiol (CBD)-based drug, was recently approved for treatment of DS. While Epidiolex shows great promise in reducing seizures in patients with DS, it is used in conjunction with other AEDs and can cause liver toxicity. To investigate whether other cannabis-derived compounds could also reduce seizures, the antiepileptic effects of CBD, Δ9-tetrahydrocannabinol (THC), cannabidivarin (CBDV), cannabinol (CBN), and linalool (LN) were compared in both a chemically-induced (pentylenetetrazole, PTZ) and a DS (scn1Lab) seizure models. Zebrafish (Danio rerio) that were either wild-type (Tupfel longfin) or scn1Lab (DS) were exposed to CBD, THC, CBDV, CBN, or LN for 24 h from 5 to 6 days postfertilization. Following exposure, total distance traveled was measured in a ViewPoint Zebrabox to determine if these compounds reduced seizure-like activity. Cannabidiol (0.6 and 1 μM) and THC (1 and 4 μM) significantly reduced PTZ-induced total distance moved. At the highest THC concentration, the significant reduction in PTZ-induced behavior was likely the result of sedation as opposed to antiseizure activity. In the DS model, CBD (0.6 μM), THC (1 μM), CBN (0.6 and 1 μM), and LN (4 μM) significantly reduced total distance traveled. Cannabinol was the most effective at reducing total distance relative to controls. In addition to CBD, other cannabis-derived compounds showed promise in reducing seizure-like activity in zebrafish. Specifically, four of the five compounds were effective in the DS model, whereas in the PTZ model, only CBD and THC were, suggesting a divergence in the mode of action among the cannabis constituents.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276876PMC
http://dx.doi.org/10.1016/j.yebeh.2020.107152DOI Listing

Publication Analysis

Top Keywords

total distance
16
cannabis constituents
8
reduce seizures
8
promise reducing
8
cannabis-derived compounds
8
cbd thc
8
distance traveled
8
seizure-like activity
8
4 μm reduced
8
model cbd
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!